CONNECT WITH US
HealthTech

HealthTech

AI may help spot early signs of lung cancer in the blood

Medical Xpress logo

Published on

Add as a preferred source on Google
AI may help spot early signs of lung cancer in the blood

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

In a blue-and-white van outside Asda last June, 68-year-old Eddie, a retired fishmonger from Fallowfield, near Manchester, received life-changing news.

The van belonged to the NHS—and it contained a portable scanner. Eddie and his wife Jeanette had arrived for a lung screening appointment, after being invited by their primary care doctor.

"I very nearly didn't go," recalls Eddie, who felt fit and well. But Jeanette insisted: it was no more difficult than a quick trip to the store.

"Because I smoked as a teenager and had some family history of cancer, they said that I should have a scan there and then," he remembers.

To the couple's shock, it found a dark shadow on Eddie's right lung. A week later, in the hospital, he had further tests, including a biopsy—and the couple's worst fears were confirmed: it was lung cancer. "I can't even properly remember the conversation. I was in total shock," Eddie says.

But screening has its downsides. False positives can cause stress and anxiety, while regular monitoring after surgery can be a stressful and time-consuming process. There are also potential harms from the radiation used in CT scans, even though the dose is low.

For these reasons, the NHS program currently only invites current and former smokers, whose higher cancer risk means the benefits outweigh these harms. But estimates suggest as many as 6,000 "never-smokers" —currently ineligible for screening—die from lung cancer every year.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.